Literature DB >> 11882464

Syndrome of myelofibrosis and osteosclerosis: a series of case reports and review of the literature.

T Diamond1, A Smith, R Schnier, A Manoharan.   

Abstract

Myelofibrosis (MF) is a chronic disorder characterized by bone marrow evidence of myeloid metaplasia associated with reactive fibrosis, angiogenesis, and osteosclerosis. We report serum biochemistry, noninvasive markers of bone turnover, tetracycline-labeled bone histomorphometry, and bone densitometry (DXA) data of four men presenting with newly diagnosed biopsy-proven MF and osteosclerosis. The mechanisms and putative growth factors responsible for this syndrome are examined.

Entities:  

Mesh:

Year:  2002        PMID: 11882464     DOI: 10.1016/s8756-3282(01)00695-0

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  9 in total

1.  Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markers.

Authors:  Sarah Farmer; Hanne Vestergaard; Stinus Hansen; Vikram Vinod Shanbhogue; Vikram Vinod Shanbhoque; Claudia Irene Stahlberg; Anne Pernille Hermann; Henrik Frederiksen
Journal:  Int J Hematol       Date:  2015-05-05       Impact factor: 2.490

2.  Computerised analysis of osteoporotic bone patterns using texture parameters characterising bone architecture.

Authors:  H Jeong; J Kim; T Ishida; M Akiyama; Y Kim
Journal:  Br J Radiol       Date:  2013-01       Impact factor: 3.039

3.  Role of Endothelin-1 in a Syndrome of Myelofibrosis and Osteosclerosis.

Authors:  Ralph Yachoui; Jasmin Kristianto; Kajal Sitwala; Robert D Blank
Journal:  J Clin Endocrinol Metab       Date:  2015-09-10       Impact factor: 5.958

Review 4.  Myeloproliferative disorders and their effects on bone homeostasis: the role of megakaryocytes.

Authors:  Aikaterini Karagianni; Katya Ravid
Journal:  Blood       Date:  2022-05-26       Impact factor: 25.476

5.  'Sink or swim': an evaluation of the clinical characteristics of individuals with high bone mass.

Authors:  C L Gregson; S A Steel; K P O'Rourke; K Allan; J Ayuk; A Bhalla; G Clunie; N Crabtree; I Fogelman; A Goodby; C M Langman; S Linton; E Marriott; E McCloskey; K E Moss; T Palferman; S Panthakalam; K E S Poole; M D Stone; J Turton; D Wallis; S Warburton; J Wass; E L Duncan; M A Brown; G Davey-Smith; J H Tobias
Journal:  Osteoporos Int       Date:  2011-04-01       Impact factor: 4.507

6.  The value of bone marrow, liver, and spleen imaging in diagnosis, prognostication, and follow-up monitoring of myeloproliferative neoplasms: a systematic review.

Authors:  Stefanie Slot; Niels W C J van de Donk; René H J Otten; Bouke J H Boden; Josée Zijlstra; Pieter G H M Raijmakers; Sonja Zweegman
Journal:  Cancer Imaging       Date:  2021-04-20       Impact factor: 3.909

Review 7.  Friend or foe: high bone mineral density on routine bone density scanning, a review of causes and management.

Authors:  Celia L Gregson; Sarah A Hardcastle; Cyrus Cooper; Jonathan H Tobias
Journal:  Rheumatology (Oxford)       Date:  2013-02-27       Impact factor: 7.580

8.  Cementless bipolar hemiarthroplasty in a patient with PMF: a case report.

Authors:  Abdullah A Alturki; Nayf A Alshammari; Firas M Alsebayel; Ali A Alhandi
Journal:  J Surg Case Rep       Date:  2019-11-15

Review 9.  The Genetic Architecture of High Bone Mass.

Authors:  Celia L Gregson; Emma L Duncan
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-29       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.